Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors

被引：0
|
作者：
Philip J. Mease [1 ]
Shannon A. Ferrante [2 ]
Natalie J. Shiff [3 ]
Timothy P. Fitzgerald [3 ]
Soumya D. Chakravarty [4 ]
Jessica A. Walsh [3 ]
机构：
[1] Providence Swedish Medical Center,Rheumatology Research
[2] University of Washington School of Medicine,Adjunct, Community Health and Epidemiology
[3] Janssen Scientific Affairs,undefined
[4] LLC,undefined
[5] a Johnson & Johnson Company,undefined
[6] University of Saskatchewan,undefined
[7] Drexel University College of Medicine,undefined
[8] Salt Lake City Veterans Affairs Health,undefined
[9] University of Utah Health,undefined
来源：
Advances in Therapy | 2025年 / 42卷 / 2期
关键词：
Guselkumab; Psoriatic arthritis; Persistence; Real-world evidence; Subcutaneous interleukin-17A inhibitors;
D O I：
10.1007/s12325-024-03042-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：734 / 751
页数：17
相关论文
共 50 条
  • [1] Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors
    Walsh, Jessica A.
    Lin, Iris
    Zhao, Ruizhi
    Shiff, Natalie J.
    Morrison, Laura
    Emond, Bruno
    Yu, Louise H.
    Schwartzbein, Samuel
    Lefebvre, Patrick
    Pilon, Dominic
    Chakravarty, Soumya D.
    Mease, Philip
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (03) : 487 - 499
  • [2] Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
    Alegre-Sancho, Juan Jose
    Nunez-Monje, Victoria
    Campos-Fernandez, Cristina
    Balaguer-Trull, Isabel
    Robustillo-Villarino, Montserrat
    Aguilar-Zamora, Marta
    Garijo-Bufort, Marta
    Pedraz-Penalva, Teresa
    Pena-Gonzalez, Carolina
    de la Morena, Isabel
    Bedoya-Sanchis, Diego
    Yankova-Komsalova, Liliya
    Conesa-Mateos, Arantxa
    Martinez-Cristobal, Anna
    Navarro-Blasco, Francisco Javier
    Senabre-Gallego, Jose Miguel
    Sivera, Francisca
    FRONTIERS IN MEDICINE, 2023, 10
  • [3] Real-world Persistence and Treatment Patterns in Psoriatic Arthritis Patients Treated with Anti-IL17 Therapy
    Joven, Beatriz E.
    Fito Manteca, Concepcion
    Rubio, Enrique
    Raya Alvarez, Enrique
    Perez, Alba
    Hernandez, Raquel
    Arija, Sara Manrique
    Nunez, Mercedes
    Diaz, Silvia
    Trancho, Luis
    Moyano, Sebastian
    Lacetera, Alessandra
    Alfaro-Oliver, Noelia
    Garcia-Vicuna, Rosario
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4239 - 4241
  • [4] REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Choi, J.
    Sreih, A.
    Lehman, T.
    Suryavanshi, M.
    Xia, Q.
    Nowak, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1564 - 1565
  • [5] Should we customize the treatment with interleukin-17A inhibitors for moderate-to-severe psoriasis in the real-world setting?
    Hu, Kun
    Zhang, Mi
    Yang, Jing
    Wang, Qiaolin
    Tan, Minjia
    Deng, Sichun
    Chen, Junchen
    Zhu, Wu
    Chen, Wendong
    Kuang, Yehong
    Chen, Xiang
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (02) : E262 - E263
  • [6] REAL-WORLD PERSISTENCE AND TREATMENT PATTERNS IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH ANTI-IL17 THERAPY: THE PERFIL-17 STUDY
    Joven Ibanez, Beatriz
    Fito Manteca, Concepcion
    Rubio, Esteban
    Raya, Enrique
    Perez-Linaza, Alba
    Hernandez, Raquel
    Manrique-Arija, Sara
    Nunez, Mercedes
    Diaz, Silvia
    Trancho, Luis
    Garcia de Vicuna, Rosario
    RHEUMATOLOGY, 2023, 62
  • [7] REAL-WORLD PERSISTENCE AND TREATMENT PATTERNS IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH ANTI-IL-17 THERAPY: THE PERFIL-17 STUDY
    Joven Ibanez, Beatriz
    Fito Manteca, Concepcion
    Rubio, Esteban
    Raya, Enrique
    Perez-Linaza, Alba
    Hernandez, Raquel
    Manrique-Arija, Sara
    Nunez, Mercedes
    Diaz, Silvia
    Trancho, Luis
    Garcia de Vicuna, Rosario
    Nash, Peter
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 38 - 38
  • [8] THE PSABio STUDY IN ITALY: A REAL-WORLD COMPARISON OF THE PERSISTENCE, EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Gremese, E.
    Ciccia, F.
    Selmi, C.
    Cuomo, G.
    Foti, R.
    Cerinic, M. Matucci
    Conti, F.
    Fusaro, E.
    Guggino, G.
    Iannone, F.
    Delle Sedie, A.
    Perricone, R.
    Idolazzi, L.
    Moscato, P.
    Theander, E.
    Noel, W.
    Bergmans, P.
    Marelli, S.
    Gossec, L.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 778 - 779
  • [9] Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis
    Malkonen, Tarja
    Nuutinen, Pauliina
    Hallinen, Taru
    Soini, Erkki
    Nissinen, Riikka
    Wennerstom, Christina
    Rantanen, Tapio
    Hagman, Johanna H.
    Harvima, Rauno
    Hook-Nikanne, Johanna
    Ilves, Tiina
    Lintu, Paivi
    Malanin, Ken
    Soramaki, Iina
    Tasanen, Kaisa
    Teho, Arja
    Vahavihu, Katja
    Italinna, Sari
    Leinonen, Pekka
    Sarajarvi, Piia
    Huilaja, Laura
    Pasternack, Rafael
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [10] Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis
    Elgaard, Cathrine Dawn Buttner
    Iversen, Lars
    Hjuler, Kasper Fjellhaugen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
12345